Tirzepatide (brand names Mounjaro and Zepbound) is a dual GIP/GLP-1 receptor agonist representing the next generation of weight loss peptides. It produces even greater weight loss than semaglutide, with clinical trials showing 20-25% body weight reduction. By activating both glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptors, tirzepatide provides superior metabolic benefits. FDA-approved for both type 2 diabetes and obesity.
Tirzepatide 30 mg – 10 Vials
$145.00
Kit of 10 Vials – For Research Use Only – Not Intended for Human Consumption
Extra Features
- Premium Quality
- Secure Payments
- Satisfaction Guarantee
- Worldwide Shipping
- Money Back Guarantee
Be the first to review “Tirzepatide 30 mg – 10 Vials”
Reviews
There are no reviews yet.